Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
MTHFD2 encodes a nuclear-encoded mitochondrial bifunctional enzyme with methylenetetrahydrofolate dehydrogenase and methenyltetrahydrofolate cyclohydrolase activities. Zusätzlich bieten wir Ihnen Methylenetetrahydrofolate Dehydrogenase (NADP+ Dependent) 2, Methenyltetrahydrofolate Cyclohydrolase Antikörper (47) und Methylenetetrahydrofolate Dehydrogenase (NADP+ Dependent) 2, Methenyltetrahydrofolate Cyclohydrolase Kits (7) und viele weitere Produktgruppen zu diesem Protein an.
Showing 8 out of 9 products:
Data suggest that Ad4BP (zeige NR5A1 Proteine) plays role in regulation of intracellular NADPH (zeige FDXR Proteine) concentration via transcription of Me1 (zeige ME1 Proteine) and Mthfd2 genes in adrenocortical cells. (Ad4BP (zeige NR5A1 Proteine) = nuclear receptor subfamily 5 group A member 1 (zeige NR5A1 Proteine); Me1 (zeige ME1 Proteine) = malic enzyme 1 (zeige ME1 Proteine); Mthfd2 = bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase)
A mutation in methylenetetrahydrofolate reductase (MTHFR (zeige MTHFR Proteine)) gene, may contribute to the risk of both arterial and deep-vein thrombosis in patients with nephrotic syndrome.
miR (zeige MLXIP Proteine)-92a inhibits proliferation and induces apoptosis by directly regulating MTHFD2 expression in AML (zeige RUNX1 Proteine).
metabolic alterations in MCF7 cells observed as a consequence of MTHFD2 suppression
crystal structure of MTHFD2 in complex with a substrate-based inhibitor and the enzyme cofactors NAD(+) and inorganic phosphate.
Mechanistically, MYC (zeige MYC Proteine) regulates the expression of MTHFD2, and MTHFD2 knockdown suppresses the TCA cycle.
siRNA-mediated silencing of MTHFD2 inhibited migration, invasion and epithelial-mesenchymal transition progression in hepatocellular carcinoma (HCC (zeige FAM126A Proteine)) cell lines, but no obvious effects on cell proliferation, apoptosis or cell cycle distribution were detected. MTHFD2 is overexpressed in HCC (zeige FAM126A Proteine), and is associated with poor prognosis and cellular features connected to metastatic disease.
These findings suggest a previously unknown role for MTHFD2 in cancer cell proliferation, adding to its known function in mitochondrial folate metabolism.
The highest scoring pathway is mitochondrial one-carbon metabolism and is centred on MTHFD2.
Data indicate that methylenetetrahydrofolate dehydrogenase (NADP + -dependent) 2 (MTHFD2)was differentially expressed in breast cancer tissue, suggesting as a prognostic factor and a potential therapeutic target for future breast cancer treatments.
Data indicate that the reduced vimentin (zeige VIM Proteine) expression in response to EPHB4 (zeige EPHB4 Proteine), WIPF2 and MTHFD2 silencing was observed at mRNA and protein levels.
This gene encodes a nuclear-encoded mitochondrial bifunctional enzyme with methylenetetrahydrofolate dehydrogenase and methenyltetrahydrofolate cyclohydrolase activities. The enzyme functions as a homodimer and is unique in its absolute requirement for magnesium and inorganic phosphate. Formation of the enzyme-magnesium complex allows binding of NAD. Alternative splicing results in two different transcripts, one protein-coding and the other not protein-coding. This gene has a pseudogene on chromosome 7.
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial
, methylene tetrahydrofolate dehydrogenase 2
, methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
, methylenetetrahydrofolate dehydrogenase 2
, NAD-dependent methylene tetrahydrofolate dehydrogenase cyclohydrolase
, methylene tetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase
, methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase